Use of indole derivatives as NURR-1 activators for treating Parkinson's disease

Details for Australian Patent Application No. 2009269842 (hide)

Owner Laboratoires Fournier S.A.

Inventors Poupardin-Olivier, Olivia; Van Vliet, Bernard Johannes; Boubia, Benaissa; Tallandier, Mireille; Den Hartog, Jacobus Antonius Joseph; Van Dongen, Maria Johanna Petronella; McCreary, Andrew

Agent Spruson & Ferguson

Pub. Number AU-A-2009269842

PCT Pub. Number WO2010/004221

Priority 08 54712 10.07.08 FR

Filing date 9 July 2009

Wipo publication date 14 January 2010

International Classifications

C07D 209/12 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/405 (2006.01)

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 209/18 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

24 February 2011 PCT application entered the National Phase

  PCT publication WO2010/004221 Priority application(s): WO2010/004221

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009269860-Apparatus and methods for effecting chemical assays

2009269836-Substituted 1-benzyl-cinnolin-4(1H)-one derivatives, preparation thereof, and therapeutic use thereof